inVentiv, Median strategic alliance brings biomarker imaging to clinical trials

By Melissa Fassbender

- Last updated on GMT

Median Technologies and inVentiv Health have announced a strategic alliance to provide medical image analysis and management services for oncology clinical trials. (Image: iStock/selvanegra)
Median Technologies and inVentiv Health have announced a strategic alliance to provide medical image analysis and management services for oncology clinical trials. (Image: iStock/selvanegra)

Related tags Clinical trial

Median Technologies will provide inVentiv Health clients with various integrated imaging services to support clients at all stages of development.

Anne Pilling, SVP, Global Project Management of inVentiv Health told Outsourcing-Pharma.com the strategic alliance will provide its customers with “the most advanced imaging biomarkers, at a time when 73% of cancer compounds in clinical trials involve biomarkers in their research and development​ design.”

inVentiv Health clients will gain access to the imaging solutions and services provider’s technology for early- to late-stage oncology trials.

No matter where our clients are in development, we’ll be able to provide support​,” said Pilling.

Early-stage clients will have access to integrated imaging services to access imaging biomarkers. For late-stage clients, Median’s management services technology will provide data integrity, reliability, and transparency.

Our clients are increasingly looking to us to provide them with innovative solutions to increase the efficiency of and accelerate the clinical trial process​,” explained Pilling.

The measurement of imaging biomarkers is a critical component of oncology research and demand for an improved methodology is high," ​she added.

"We believe that Median’s technology offers a smarter solution that will be welcomed by our oncology clients.​”

Related news

Show more

Related products

show more

Drug Solubility and the Need for Speed

Drug Solubility and the Need for Speed

Lonza Small Molecules | 28-Mar-2023 | Technical / White Paper

A growing number of new chemical entities are highly insoluble, leading to problems with bioavailability. Drug manufacturers therefore have to find ways...

Are You Prepared to Meet the New FDA Guidelines?

Are You Prepared to Meet the New FDA Guidelines?

Elligo Health Research® | 23-Mar-2023 | Insight Guide

On April 15, 2022, the U.S. Food and Drug Administration issued a new draft guidance to clinical research sponsors on creating a plan to enroll more participants...

ODM and CDASH in CRF design

ODM and CDASH in CRF design

Formedix | 10-Mar-2023 | Technical / White Paper

The lesser-known Operational Data Model (ODM) standard is often overlooked as it's not required by any regulators. So, why should you be interested...

4 Warning Signs Your Research Site Is in Trouble

4 Warning Signs Your Research Site Is in Trouble

Elligo Health Research® | 10-Mar-2023 | Insight Guide

You want your clinical research practice to be a success for your business and your patients, but how can you tell if it’s in trouble? Read this article...

Related suppliers

Follow us

Products

View more

Webinars